Navigation Links
Nutrastar Announces Full Year 2012 Results, Issues 2013 Revenue Guidance
Date:3/29/2013

HER COMPREHENSIVE INCOME: Foreign currency translation adjustments 250,4452,956,953COMPREHENSIVE INCOME$17,493,156$19,939,920Earnings per share Basic

$

1.10$

1.12Diluted

$

1.04$

1.04Weighted average number of shares outstanding Basic 15,453,65614,784,564Diluted 16,600,05316,339,999NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(AMOUNTS EXPRESSED IN US DOLLARS) December 31,20122011ASSETSCURRENT ASSETS  Cash and cash equivalents

$

75,526,533$

54,556,329 Restricted cash -4,170 Accounts receivable 81,49782,516 Inventories 965,251898,871 Prepayments and other receivables 1,321,7261,194,466Total current assets 77,895,00756,736,352OTHER ASSETS  Intangible assets, net 1,552,0222,024,593 Property, plant and equipment, net15,991,06012,395,567 Construction in process -5,271,609Total assets$95,438,089$76,428,121LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIES  Accounts payable

$

-$

6,339 Other payables and accruals 1,481,1981,064,045 Taxes payable 2,981,1362,585,738 Due to a related party 150,03680,648 Preferred stock dividend payable 528,528529,851 Warrants liabilities 173144,411Total current liabilities 5,141,0714,411,032Total liabilities 5,141,0714,411,032COMMITMENTS AND CONTINGENCIES (Note 19) STOCKHOLDERS' EQUITY  Preferred Stock, $0.001 par value, (1,000,000 shares authorized,
 113,010 shares and 147,820 shares issued and outstanding, respectively;
 aggregate liquidation preference amount: $3,164,280 and $4,138,960,
 plus accrued but unpaid dividend of $528,528 and $529,851,
 at December 31, 2012 and 2011, respectively 2,577,3243,371,206 Common stock, $0.001 par value, 190,000,000 shares authorized,
5,907,381 shares issued and 15,863,826 shares outstanding at
December 31, 2012; 14,962,631 shares issued and 14,
'/>"/>

SOURCE Nutrastar International Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
2. International Isotopes Inc. Announces 2012 Year End Financial Results
3. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
4. ShangPharma Corporation Announces Completion of Merger
5. ReSearch Pharmaceutical Services Announces Joint Venture with Asklep in Japan
6. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
7. CleanPath Resources Corp Announces Worldwide Exclusive Stem Cell Enhancement Agreement with a Division of Hemp, Inc.
8. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
9. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
10. TriReme Announces Signing of a Master Distribution Agreement in China
11. Genalyte Announces CE Mark For Maverick(TM) Detection System And Signs On First European Distributors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...   , First patient ... efficacy and safety of MSB0010718C in patients with metastatic Merkel ... aggressive skin cancer lacking effective treatments   MSB0010718C is ... clinical trial for the treatment of solid tumors that aims ... a subsidiary of Merck KGaA, Darmstadt, Germany ...
(Date:7/28/2014)... , July 28, 2014  Dignity Health St. ... received the Get With The Guidelines®-Stroke Silver-Plus Quality ... outlined by the American Heart Association/American Stroke Association ... the number four cause of death and a ... the United States , according to the ...
(Date:7/28/2014)... , July 28, 2014 STAAR Surgical ... manufacturer and marketer of implantable lenses and delivery systems ... second quarter results and conference call with investors to ... 30, 2014.  The Company rescheduled the release date and ... funeral services for Hideo Watanabe , President of ...
Breaking Medicine Technology:EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2
... K-V Pharmaceutical Company ( KVa; KVb) (the "Company") ... HOLX ) that site initiation and patient enrollment has ... in the ongoing trial of Gestiva™ (hydroxyprogesterone caproate injection, 250 ... of preterm birth in women pregnant with a single baby ...
... The Wireless-Life Sciences Alliance (WLSA) , which convenes innovators, globally relevant ... in wireless technologies, today hailed its partner organizations for their collaboration and ... , , ... , , ...
Cached Medicine Technology:K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 2K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 3K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 4K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 5K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 6K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 7K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 8K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 9Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 2Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 3
(Date:7/29/2014)... (PRWEB) July 29, 2014 The Latin American ... the market with analysis and forecast of revenue. The poultry ... to grow from $25,273.3 million and $647.2 million in 2013 ... CAGR of 6.1% from 2013 to 2018, respectively. , To ... browse through the TOC of the Latin American poultry feed ...
(Date:7/29/2014)... July 29, 2014 Frank Davis, Activz ... can help parents add nutrition to their kids’ meals ... – Key market drivers in kids’ foods market” by ... pleased to announce the interview Frank Davis had with ... Activz organic vegetable and fruit produce powders to kids ...
(Date:7/29/2014)... News) -- Decorative contact lenses may seem like a ... cause serious eye damage. Decorative contacts should be ... the U.S. Food and Drug Administration (FDA). It,s important ... for these lenses and buy them from a trustworthy ... about the potential health risks associated with decorative contact ...
(Date:7/29/2014)... including Penn State College of Medicine, have jointly ... a health data research network., The Patient-Centered Outcomes ... Patient Protection and Affordable Care Act, awarded the ... University and Johns Hopkins University -- and each ... have come together to create a Clinical Data ...
(Date:7/29/2014)... July 29, 2014 – Silverado, a provider of memory ... that it is a Bronze winner in the 35th Annual ... Through a Child's Eye and Silverado Resident Visits ... a Child's Eye , seven-year-old Mia Sandoval shares her experience ... a memory care community in Los Angeles. The feel-good video ...
Breaking Medicine News(10 mins):Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:It's 'Buyer Beware' for Decorative Contact Lenses, FDA Says 2Health News:New network unites university health care research 2Health News:Silverado Selected a Winner in the 35th Annual Telly Awards for Producing Inspiring Online Video Content 2
... research suggests , THURSDAY, July 30 (HealthDay News) -- ... in patients with head and neck cancer, U.S. researchers ... black Americans, who have far less HPV infection than ... , "There is currently no consensus on why blacks ...
... , , YOUNTVILLE, Calif., July 30 ... , WHAT: A special hearing of the California Senate Veterans ... The hearing was originally , scheduled for Friday, July 31, 2009 ... , , , ...
... , PASADENA, Calif., July ... announced its licensee, BioMS Medical Corp., and Eli Lilly ... primary endpoint of delaying disease progression, as measured by ... Phase III trial in patients with secondary progressive multiple ...
... , , EATONTOWN, N.J., July 30 Osteotech, ... field of biologic products for regenerative healing, announced today that its ... 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel ... (EDT). , , A live, listen-only webcast of ...
... , , NEW YORK, July ... results for the three months ended June 30, 2009. , , ... revenue grew by 18% as we see continuing demand from both pharmaceutical as ... Gattinella, President and CEO. "I am enthusiastic about the momentum we are gaining ...
... , , , WASHINGTON, July ... private, employer-based coverage if Congress passes a House health reform bill, ... Choices Act of 2009 released this week by ... Heritage commissioned The Lewin Group , a ...
Cached Medicine News:Health News:Virus May Affect Survival in Head and Neck Cancer 2Health News:Clinical Trial by Licensee Does Not Meet Primary Endpoint 2Health News:WebMD Announces Second Quarter Financial Results 2Health News:WebMD Announces Second Quarter Financial Results 3Health News:WebMD Announces Second Quarter Financial Results 4Health News:WebMD Announces Second Quarter Financial Results 5Health News:WebMD Announces Second Quarter Financial Results 6Health News:WebMD Announces Second Quarter Financial Results 7Health News:WebMD Announces Second Quarter Financial Results 8Health News:WebMD Announces Second Quarter Financial Results 9Health News:WebMD Announces Second Quarter Financial Results 10Health News:WebMD Announces Second Quarter Financial Results 11Health News:WebMD Announces Second Quarter Financial Results 12Health News:WebMD Announces Second Quarter Financial Results 13Health News:WebMD Announces Second Quarter Financial Results 14Health News:WebMD Announces Second Quarter Financial Results 15Health News:WebMD Announces Second Quarter Financial Results 16Health News:WebMD Announces Second Quarter Financial Results 17Health News:WebMD Announces Second Quarter Financial Results 18Health News:WebMD Announces Second Quarter Financial Results 19Health News:Thousands of Nebraskans Could Lose Private Insurance, Study Shows 2
... Drug Interaction Principles is the number one ... , An understanding of drug interactions has ... Since publication of the first edition of ... pharmacopoeia - coupled with prolonged human life ...
... drug information reference that integrates ... patient care guidelines., The sixth ... 4,700 drugs, including the latest ... indications, dosages, side effects and ...
Updated for 2006 with more than 800 complete drug entries, this mobile reference provides instant access to all the drug information nurses need in day-to-day practice....
... ACM-8 loads and unloads two centrifuges with ... via Cap Recognition the tube type is ... batches of three 5 position racks into ... single centrifuge ACM can be offered for ...
Medicine Products: